Menu
Menu
In order to establish the efficacy and effectiveness of a medicine or device during clinical trials, biostatistics is an essential component of any investigational drug or device development programme. This comprises the designs of the studies, the conduct of the studies, the determination of the most effective data collection points, and how the analysis and reporting should be carried out.
Our biostatisticians have a drive for excellence and implement the best method to a client’s condition or scenario to ensure that correct analysis is performed without an overly complex process. We are able to demonstrate that a medication is effective by utilising the necessary instruments, and we can provide the findings in the most understandable manner feasible.
If you have the data on your side, you will be better positioned to make well-considered decisions at every stage of the clinical development and commercialization processes. Our Clinical Biostatistics team dives deep into your data to assist you in planning, carrying out, and analysing each step of the process.
Because we have a team of committed statisticians, we are able to assist you with the following:
Design of the trial that is group-sequential and adaptive with cooperation from the Data Monitoring Committee (DMC) . Research that consists only of observations, often known as non-interventional studies Biosimilars
